Clinical Trial Update: Study of PF-07263689 in Participants With Selected Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial of PF-07263689 in selected advanced solid tumors was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Colorectal Cancer
• Head and Neck Cancer
• Hepatocellular Cancer
• Melanoma
• Non-small Cell Lung Cancer
• Ovarian Cancer
• Renal Cell Cancer
• Sarcoma
• Squamous Cell Carcinoma

Drugs mentioned

• PF-07263689

Snippet

Sponsor: Pfizer | Conditions: Renal Cell Cancer, Melanoma | Phase 1 | Status: TERMINATED | Results posted: 2024-04-12